Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gastrointestinal Cancer

Breast Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Gastrointestinal Cancer

Investigators Test Breakthrough-Designated Triplet in First-Line CRC

Investigators hope to answer a potentially paradigm-changing question in the phase II ANCHOR-CRC study (NCT03693170) of BRAF V600E–mutant colorectal cancer (CRC): Can the benefit observed with a targeted triplet in latestage disease extend...
Read More >>

Molecular Testing for Colon Cancer Falls Far Short of the Guidelines

Novel Agents Generate Excitement in Advanced HCC, Cholangiocarcinoma

Role of Immunotherapy Agents Grows in Metastatic Colorectal Cancer

Questions Remain in Localized Pancreatic Cancer as More Treatment Modalities Emerge

Oncologists Outline Ongoing Research Efforts Across GI Cancers, GBM

View More Stories >>

View Conference Coverage

2019 San Antonio Breast Cancer Symposium

2019 ASH Annual Meeting

2019 International Congress of the Society for Melanoma Research

2019 State of the Science Summit on Genitourinary Cancers in Nashville

2019 State of the Science Summit on Hematologic Malignancies in Chicago

Dr. Ribeiro on Criteria for Determining Borderline Resectability in Pancreatic Cancer

Dr. Ferraro on the Use of Molecular Profiling in Pancreatic Cancer

Dr. Hussein On the Evolution of Treatment in HCC

Dr. Lockhart on Strategies for Targeting the RAS/RAF/MEK/ERK Pathway in CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Final Thoughts on CCA

ClarIDHy Phase III Trial of Ivosidenib in CCA

Hepatocellular Carcinoma: Future Directions in Care

Perioperative Approaches to HCC Management

Ivosidenib for Advanced IDH1-Mutated CCA

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

The Future of Personalized Therapy in Advanced HCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

Andrew Ko, MD, professor, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, provides insight on PEGPH20 for patients with pancreatic adenocarcinoma. View Now

Sequencing Decisions in Gastroesophageal Cancers

Led by Johanna Bendell, MD, panelists Ian Chau, MD; Yelena Y. Janjigian, MD; Manish A. Shah, MD; and Kohei Shitara, MD, focus on sequencing decisions for patients with gastroesophageal cancers. View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approvals in Urothelial Cancer and GIST, Promising Data in Urothelial Carcinoma, and More